Charter Hall Retail REIT (ASX:CQR) Releases 2025 Half Year Results
Charter Hall Retail REIT (ASX:CQR) announces a 7% decrease in operating earnings for 1H 2025, alongside strategic acquisitions and a stable distribution per unit.
Sunrise Energy Metals Limited (ASX:SRL) Renews Aluminium-Scandium Research Agreement
Sunrise Energy Metals (ASX:SRL) renews research agreement with UACJ Corporation to develop aluminium-scandium alloys for automotive applications.
GQG Partners (ASX:GQG) Reports 2024 Full Year Results
GQG Partners (ASX:GQG) reports a 26.9% increase in funds under management and a 46.9% rise in net revenue for 2024, alongside a 90% dividend payout ratio.
Olympio Metals Limited (ASX:OLY) Announces Sale of Halls Creek Tenements
Olympio Metals (ASX:OLY) enters option agreement to sell Halls Creek tenements, focusing on its Canadian Dufay Cu-Au Project.
HealthCo Healthcare & Wellness REIT (ASX:HCW) Announces 1H FY25 Results
HealthCo Healthcare & Wellness REIT (ASX:HCW) reports a 5% growth in FFO/unit and DPU for 1H FY25, reaffirming its FY25 guidance.
Meridian Energy Limited (ASX:MEZ) Releases January Operating Report
Meridian Energy Limited (ASX:MEZ) releases its January 2025 operating report, detailing hydro storage levels, retail sales trends, and generation performance.
WAM Capital Limited (ASX:WAM) Reports Strong Portfolio Performance and Maintains Interim Dividend
WAM Capital (ASX:WAM) outperforms key indices by up to 9.4%, declares a 7.75c interim dividend, driven by a robust investment portfolio.
AMP Limited (ASX:AMP) Announces FY24 Financial Results
AMP Limited (ASX:AMP) reports a 15.1% increase in underlying NPAT for FY24, alongside cost reductions and a final dividend declaration.
AVITA Medical (ASX:AVH) Reports Q4 and FY 2024 Financial Results
AVITA Medical (ASX:AVH) reports a 30% revenue increase in Q4 and FDA approvals, setting the stage for significant growth in FY 2025.
Cochlear Limited (ASX:COH) Announces Half-Year 2024 Financial Results
Cochlear Limited (ASX:COH) reports a 5% revenue increase and an 8% interim dividend rise for the half year ended December 2024.